Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer

• Tai-Kuang Chao,

  Roles Funding acquisition, Investigation, Methodology, Writing – original draft

  Affiliations Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Department of Pathology, Tri-Service General Hospital, National Defense Medical Centre, Taipei, Taiwan, Laboratory of Epigenetics and Cancer Stem Cells, National Defense Medical Centre, Taipei, Taiwan

  ⨯
• Tien-Shuo Huang,

  Roles Methodology, Software

  Affiliations Laboratory of Epigenetics and Cancer Stem Cells, National Defense Medical Centre, Taipei, Taiwan, Department of Obstetrics and Gynecology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City, Taiwan, Department of Obstetrics and Gynecology, School of medicine, College of medicine, Taipei Medical University, Taipei, Taiwan

  ⨯
• Yu-Ping Liao,

  Roles Investigation, Methodology

  Affiliations Laboratory of Epigenetics and Cancer Stem Cells, National Defense Medical Centre, Taipei, Taiwan, Department of Obstetrics and Gynecology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City, Taiwan, Department of Obstetrics and Gynecology, School of medicine, College of medicine, Taipei Medical University, Taipei, Taiwan

  ⨯
• Rui-Lan Huang,

  Roles Methodology, Software

  Affiliations Laboratory of Epigenetics and Cancer Stem Cells, National Defense Medical Centre, Taipei, Taiwan, Department of Obstetrics and Gynecology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City, Taiwan, Department of Obstetrics and Gynecology, School of medicine, College of medicine, Taipei Medical University, Taipei, Taiwan

  ⨯
• Po-Hsuan Su,

  Roles Investigation, Methodology, Software

  Affiliations Laboratory of Epigenetics and Cancer Stem Cells, National Defense Medical Centre, Taipei, Taiwan, Department of Obstetrics and Gynecology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City, Taiwan, Department of Obstetrics and Gynecology, School of medicine, College of medicine, Taipei Medical University, Taipei, Taiwan

  ⨯
• Hueng-Yuan Shen,

  Roles Methodology

  Affiliation Department of Nuclear Medicine and PET center, Tri-Service General Hospital, National Defense Medical Centre, Taipei, Taiwan

  ⨯
• Hung-Cheng Lai,

  Roles Conceptualization

  Affiliations Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Laboratory of Epigenetics and Cancer Stem Cells, National Defense Medical Centre, Taipei, Taiwan, Department of Obstetrics and Gynecology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City, Taiwan, Department of Obstetrics and Gynecology, School of medicine, College of medicine, Taipei Medical University, Taipei, Taiwan

  ⨯
• Yu-Chi Wang

  Roles Conceptualization, Funding acquisition, Investigation, Writing – original draft, Writing – review & editing

  * E-mail: yuchitsgh@ndmctsgh.edu.tw

  Affiliations Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Laboratory of Epigenetics and Cancer Stem Cells, National Defense Medical Centre, Taipei, Taiwan, Department of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Centre, Taipei, Taiwan

  ⨯